These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10985312)

  • 1. Plasmid interleukin 12.
    Weiner D
    AIDS; 2000 Aug; 14(12):1759-60. PubMed ID: 10985312
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.
    Boyer JD; Cohen AD; Ugen KE; Edgeworth RL; Bennett M; Shah A; Schumann K; Nath B; Javadian A; Bagarazzi ML; Kim J; Weiner DB
    AIDS; 2000 Jul; 14(11):1515-22. PubMed ID: 10983638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8
    Li SS; Kochar NK; Elizaga M; Hay CM; Wilson GJ; Cohen KW; De Rosa SC; Xu R; Ota-Setlik A; Morris D; Finak G; Allen M; Tieu HV; Frank I; Sobieszczyk ME; Hannaman D; Gottardo R; Gilbert PB; Tomaras GD; Corey L; Clarke DK; Egan MA; Eldridge JH; McElrath MJ; Frahm N;
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28931520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic acid-based vaccines as an approach to immunization against human immunodeficiency virus type-1.
    Bagarazzi ML; Boyer JD; Ayyavoo V; Weiner DB
    Curr Top Microbiol Immunol; 1998; 226():107-43. PubMed ID: 9479839
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
    Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
    J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HIV vaccine pipeline, from preclinical to phase III.
    Schultz AM; Bradac JA
    AIDS; 2001; 15 Suppl 5():S147-58. PubMed ID: 11816163
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV-DNA vaccination following transfer of a large number of activated T cells enhances immunoresponses against HIV-1.
    Hamajima K; Xin KQ; Fukushima J; Yang J; Honsho A; Nakazawa M; Yanoma S; Okuda K
    Viral Immunol; 2000; 13(1):3-8. PubMed ID: 10733163
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles.
    Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M
    Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid-based immunization against HIV-I: induction of protective in vivo immune responses.
    Wang B; Boyer JD; Ugen KE; Srikantan V; Ayyaroo V; Agadjanyan MG; Williams WV; Newman M; Coney L; Carrano R
    AIDS; 1995; 9 Suppl A():S159-70. PubMed ID: 8819582
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA gene vaccination for HIV.
    Kim JJ; Weiner DB
    Springer Semin Immunopathol; 1997; 19(2):175-94. PubMed ID: 9406345
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?
    Sutter G; Haas J
    AIDS; 2001; 15 Suppl 5():S139-45. PubMed ID: 11816162
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV gp160 vaccine gene therapy (Wyeth-Lederle Vaccines-Malvern).
    Drugs R D; 1999 Jun; 1(6):451-2. PubMed ID: 10566081
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA and other technologies for HIV vaccines.
    Bowers M
    BETA; 1998 Apr; ():9-12, 28. PubMed ID: 11365275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitin Micro-Particles (CMP): a useful adjuvant for inducing viral specific immunity when delivered intranasally with an HIV-DNA vaccine.
    Hamajima K; Kojima Y; Matsui K; Toda Y; Jounai N; Ozaki T; Xin KQ; Strong P; Okuda K
    Viral Immunol; 2003; 16(4):541-7. PubMed ID: 14733740
    [No Abstract]   [Full Text] [Related]  

  • 17. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques.
    Hirao LA; Wu L; Khan AS; Satishchandran A; Draghia-Akli R; Weiner DB
    Vaccine; 2008 Jan; 26(3):440-8. PubMed ID: 18082294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
    Akahata W; Yang ZY; Nabel GJ
    J Virol; 2005 Jan; 79(1):626-31. PubMed ID: 15596858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration.
    Barouch DH; Santra S; Steenbeke TD; Zheng XX; Perry HC; Davies ME; Freed DC; Craiu A; Strom TB; Shiver JW; Letvin NL
    J Immunol; 1998 Aug; 161(4):1875-82. PubMed ID: 9712056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
    Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
    Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.